3rd Annual Atlanta Precision Oncology Symposium
2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequencing Choice for EGFRm Patients? When to Discontinue TKI Therapy? How to Approach Patients on Maintenance?
Login to view comments.
Click here to Login